|
| Status |
Public on Oct 07, 2015 |
| Title |
Primary AML patient 1302 |
| Sample type |
genomic |
| |
|
| Source name |
Primary AML patient
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: blood
dnmt3a mutation status: Wildtype
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
DNA extracted by Phenol:Chloroform:Isoamylalcohol (Sigma)
|
| Label |
Cy3/Cy5
|
| Label protocol |
Standard Illumina labelling protocol
|
| |
|
| Hybridization protocol |
Bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using High Scan SQ using standard recommended Illumina scanner setting
|
| Data processing |
Genome Studio V2011.2. Unmethylated and methylated signal intensities included in signals_AML.txt file.
|
| |
|
| Submission date |
Oct 14, 2014 |
| Last update date |
Oct 07, 2015 |
| Contact name |
Manel Esteller |
| Organization name |
IDIBELL
|
| Department |
PEBC
|
| Lab |
Cancer Epigenetics
|
| Street address |
Hospital Duran i Reynals Av. Gran Via s/n km, 2.7
|
| City |
L'Hospitalet de Llobregat |
| State/province |
Barcelona |
| ZIP/Postal code |
08908 |
| Country |
Spain |
| |
|
| Platform ID |
GPL13534 |
| Series (2) |
| GSE62298 |
Genome-scale profiling of the DNA methylation landscape in human AML patients |
| GSE62303 |
DNA methylation landscape in AML |
|
